Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 176

1.

Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR.

Berthold F, Faldum A, Ernst A, Boos J, Dilloo D, Eggert A, Fischer M, Frühwald M, Henze G, Klingebiel T, Kratz C, Kremens B, Krug B, Leuschner I, Schmidt M, Schmidt R, Schumacher-Kuckelkorn R, von Schweinitz D, Schilling FH, Theissen J, Volland R, Hero B, Simon T.

Ann Oncol. 2020 Mar;31(3):422-429. doi: 10.1016/j.annonc.2019.11.011. Epub 2020 Jan 24.

2.

Do computerized clinical decision support systems improve the prescribing of oral anticoagulants? A systematic review.

Sennesael AL, Krug B, Sneyers B, Spinewine A.

Thromb Res. 2020 Mar;187:79-87. doi: 10.1016/j.thromres.2019.12.023. Epub 2020 Jan 7.

PMID:
31972381
3.

Comparison of Subpectoral versus Prepectoral Immediate Implant Reconstruction after Skin- and Nipple-Sparing Mastectomy in Breast Cancer Patients: A Retrospective Hospital-Based Cohort Study.

Thangarajah F, Treeter T, Krug B, Hellmich M, Eichler C, Hanstein B, Mallmann P, Malter W.

Breast Care (Basel). 2019 Dec;14(6):382-387. doi: 10.1159/000496696. Epub 2019 Feb 26.

4.

Stalled developmental programs at the root of pediatric brain tumors.

Jessa S, Blanchet-Cohen A, Krug B, Vladoiu M, Coutelier M, Faury D, Poreau B, De Jay N, Hébert S, Monlong J, Farmer WT, Donovan LK, Hu Y, McConechy MK, Cavalli FMG, Mikael LG, Ellezam B, Richer M, Allaire A, Weil AG, Atkinson J, Farmer JP, Dudley RWR, Larouche V, Crevier L, Albrecht S, Filbin MG, Sartelet H, Lutz PE, Nagy C, Turecki G, Costantino S, Dirks PB, Murai KK, Bourque G, Ragoussis J, Garzia L, Taylor MD, Jabado N, Kleinman CL.

Nat Genet. 2019 Dec;51(12):1702-1713. doi: 10.1038/s41588-019-0531-7. Epub 2019 Nov 25.

PMID:
31768071
5.

Impulsive stimulated Brillouin microscopy for non-contact, fast mechanical investigations of hydrogels.

Krug B, Koukourakis N, Czarske JW.

Opt Express. 2019 Sep 16;27(19):26910-26923. doi: 10.1364/OE.27.026910.

PMID:
31674562
6.

Evaluation of 3.0-T MRI Brain Signal after Exposure to Gadoterate Meglumine in Women with High Breast Cancer Risk and Screening Breast MRI.

Bennani-Baiti B, Krug B, Giese D, Hellmich M, Bartsch S, Helbich TH, Baltzer PAT.

Radiology. 2019 Dec;293(3):523-530. doi: 10.1148/radiol.2019190847. Epub 2019 Oct 22.

PMID:
31638488
7.

Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M Gliomas.

Krug B, De Jay N, Harutyunyan AS, Deshmukh S, Marchione DM, Guilhamon P, Bertrand KC, Mikael LG, McConechy MK, Chen CCL, Khazaei S, Koncar RF, Agnihotri S, Faury D, Ellezam B, Weil AG, Ursini-Siegel J, De Carvalho DD, Dirks PB, Lewis PW, Salomoni P, Lupien M, Arrowsmith C, Lasko PF, Garcia BA, Kleinman CL, Jabado N, Mack SC.

Cancer Cell. 2019 Sep 16;36(3):338-339. doi: 10.1016/j.ccell.2019.08.012. No abstract available.

8.

First Reported Use of the Faxitron LOCalizer™ Radiofrequency Identification (RFID) System in Europe - A Feasibility Trial, Surgical Guide and Review for Non-palpable Breast Lesions.

Malter W, Holtschmidt J, Thangarajah F, Mallmann P, Krug B, Warm M, Eichler C.

In Vivo. 2019 Sep-Oct;33(5):1559-1564. doi: 10.21873/invivo.11637.

9.

Residual glandular tissue (RGT) in BRCA1/2 germline mutation carriers with unilateral and bilateral prophylactic mastectomies.

Grinstein O, Krug B, Hellmic M, Siedek F, Malter W, Burke C, Schmutzler R, Maintz D, Rhiem K.

Surg Oncol. 2019 Jun;29:126-133. doi: 10.1016/j.suronc.2019.04.009. Epub 2019 May 3.

PMID:
31196476
10.

Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M Gliomas.

Krug B, De Jay N, Harutyunyan AS, Deshmukh S, Marchione DM, Guilhamon P, Bertrand KC, Mikael LG, McConechy MK, Chen CCL, Khazaei S, Koncar RF, Agnihotri S, Faury D, Ellezam B, Weil AG, Ursini-Siegel J, De Carvalho DD, Dirks PB, Lewis PW, Salomoni P, Lupien M, Arrowsmith C, Lasko PF, Garcia BA, Kleinman CL, Jabado N, Mack SC.

Cancer Cell. 2019 May 13;35(5):782-797.e8. doi: 10.1016/j.ccell.2019.04.004. Erratum in: Cancer Cell. 2019 Sep 16;36(3):338-339.

PMID:
31085178
11.

Improvements of diagnostic accuracy and visualization of vertebral metastasis using multi-level virtual non-calcium reconstructions from dual-layer spectral detector computed tomography.

Abdullayev N, Große Hokamp N, Lennartz S, Holz JA, Romman Z, Pahn G, Neuhaus V, Maintz D, Krug B, Borggrefe J.

Eur Radiol. 2019 Nov;29(11):5941-5949. doi: 10.1007/s00330-019-06233-5. Epub 2019 Apr 30.

PMID:
31041562
12.

H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2/me3 and is essential for glioma tumorigenesis.

Harutyunyan AS, Krug B, Chen H, Papillon-Cavanagh S, Zeinieh M, De Jay N, Deshmukh S, Chen CCL, Belle J, Mikael LG, Marchione DM, Li R, Nikbakht H, Hu B, Cagnone G, Cheung WA, Mohammadnia A, Bechet D, Faury D, McConechy MK, Pathania M, Jain SU, Ellezam B, Weil AG, Montpetit A, Salomoni P, Pastinen T, Lu C, Lewis PW, Garcia BA, Kleinman CL, Jabado N, Majewski J.

Nat Commun. 2019 Mar 19;10(1):1262. doi: 10.1038/s41467-019-09140-x.

13.

High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer.

Bick U, Engel C, Krug B, Heindel W, Fallenberg EM, Rhiem K, Maintz D, Golatta M, Speiser D, Rjosk-Dendorfer D, Lämmer-Skarke I, Dietzel F, Schäfer KWF, Leinert E, Weigel S, Sauer S, Pertschy S, Hofmockel T, Hagert-Winkler A, Kast K, Quante A, Meindl A, Kiechle M, Loeffler M, Schmutzler RK; German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC).

Breast Cancer Res Treat. 2019 May;175(1):217-228. doi: 10.1007/s10549-019-05152-9. Epub 2019 Feb 6.

PMID:
30725383
14.

A mechanistic classification of clinical phenotypes in neuroblastoma.

Ackermann S, Cartolano M, Hero B, Welte A, Kahlert Y, Roderwieser A, Bartenhagen C, Walter E, Gecht J, Kerschke L, Volland R, Menon R, Heuckmann JM, Gartlgruber M, Hartlieb S, Henrich KO, Okonechnikov K, Altmüller J, Nürnberg P, Lefever S, de Wilde B, Sand F, Ikram F, Rosswog C, Fischer J, Theissen J, Hertwig F, Singhi AD, Simon T, Vogel W, Perner S, Krug B, Schmidt M, Rahmann S, Achter V, Lang U, Vokuhl C, Ortmann M, Büttner R, Eggert A, Speleman F, O'Sullivan RJ, Thomas RK, Berthold F, Vandesompele J, Schramm A, Westermann F, Schulte JH, Peifer M, Fischer M.

Science. 2018 Dec 7;362(6419):1165-1170. doi: 10.1126/science.aat6768.

PMID:
30523111
15.

Correction to: Development of a tool for benchmarking of clinical pharmacy activities.

Cillis M, Spinewine A, Krug B, Quennery S, Wouters D, Dalleur O.

Int J Clin Pharm. 2018 Dec;40(6):1624. doi: 10.1007/s11096-018-0741-6.

PMID:
30488159
16.

Development of a tool for benchmarking of clinical pharmacy activities.

Cillis M, Spinewine A, Krug B, Quennery S, Wouters D, Dalleur O.

Int J Clin Pharm. 2018 Dec;40(6):1462-1473. doi: 10.1007/s11096-018-0725-6. Epub 2018 Sep 21. Erratum in: Int J Clin Pharm. 2018 Nov 29;:.

PMID:
30242587
17.

Bone marrow edema in traumatic vertebral compression fractures: Diagnostic accuracy of dual-layer detector CT using calcium suppressed images.

Neuhaus V, Lennartz S, Abdullayev N, Große Hokamp N, Shapira N, Kafri G, Holz JA, Krug B, Hellmich M, Maintz D, Borggrefe J.

Eur J Radiol. 2018 Aug;105:216-220. doi: 10.1016/j.ejrad.2018.06.009. Epub 2018 Jun 13.

PMID:
30017283
18.

Video-recording consultations for educational purposes in out-of-hours primary care: patients and physicians are willing to participate.

Krug B, Colliers A, Matthys J, Anthierens S, Philips H, Damen J, Coenen S, Remmen R.

Acta Clin Belg. 2019 Apr;74(2):65-69. doi: 10.1080/17843286.2018.1459231. Epub 2018 Apr 2.

PMID:
29609529
19.

Partial economic evaluation of clinical pharmacy interventions on the prescription of direct oral anticoagulants in a teaching hospital.

Declaye C, Sennesael AL, Larock AS, Spinewine A, Krug B.

Eur J Hosp Pharm. 2018 Mar;25(e1):e66-e69. doi: 10.1136/ejhpharm-2016-001024. Epub 2017 Jan 2.

20.

Effects of Contrast Enhancement on In-Body Calibrated Phantomless Bone Mineral Density Measurements in Computed Tomography.

Abdullayev N, Neuhaus VF, Bratke G, Voss S, Große Hokamp N, Hellmich M, Krug B, Maintz D, Borggrefe J.

J Clin Densitom. 2018 Jul - Sep;21(3):360-366. doi: 10.1016/j.jocd.2017.10.001. Epub 2017 Oct 23.

PMID:
29169662
21.

Treatment options for metastatic colorectal cancer in patients with liver dysfunction due to malignancy.

Faugeras L, Dili A, Druez A, Krug B, Decoster C, D'Hondt L.

Crit Rev Oncol Hematol. 2017 Jul;115:59-66. doi: 10.1016/j.critrevonc.2017.03.029. Epub 2017 Mar 29. Review.

22.

2017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic Tumors.

Simon T, Hero B, Schulte JH, Deubzer H, Hundsdoerfer P, von Schweinitz D, Fuchs J, Schmidt M, Prasad V, Krug B, Timmermann B, Leuschner I, Fischer M, Langer T, Astrahantseff K, Berthold F, Lode H, Eggert A.

Klin Padiatr. 2017 May;229(3):147-167. doi: 10.1055/s-0043-103086. Epub 2017 May 30.

PMID:
28561228
23.

Optimizing laboratory test utilization in long-term acute care hospitals.

Mora A, Krug BS, Grigonis AM, Dawson A, Jing Y, Hammerman SI.

Proc (Bayl Univ Med Cent). 2017 Jan;30(1):26-29.

24.

Treatment and outcome of Ganglioneuroma and Ganglioneuroblastoma intermixed.

Decarolis B, Simon T, Krug B, Leuschner I, Vokuhl C, Kaatsch P, von Schweinitz D, Klingebiel T, Mueller I, Schweigerer L, Berthold F, Hero B.

BMC Cancer. 2016 Jul 27;16:542. doi: 10.1186/s12885-016-2513-9.

25.

Effects of early contrast-enhanced computed tomography on clinical course and complications in patients with acute pancreatitis.

Demir M, Foerster U, Hoffmann V, Pelc A, Schreiter I, Chang DH, Krug B, Christ H, Steffen HM.

Z Gastroenterol. 2016 Jul;54(7):642-6. doi: 10.1055/s-0042-101961. Epub 2016 Jul 18.

PMID:
27429101
26.

Association of Quality and Quantity of Bone Metastases and Computed Tomography Volumetric Bone Mineral Density With Prevalence of Vertebral Fractures in Breast Cancer Patients.

Neuhaus V, Abdullayev N, Hellmich M, Krämer S, Maintz D, Krug B, Borggrefe J.

Clin Breast Cancer. 2016 Oct;16(5):402-409. doi: 10.1016/j.clbc.2016.05.010. Epub 2016 May 31.

PMID:
27346706
27.

Electronic tools to support medication reconciliation: a systematic review.

Marien S, Krug B, Spinewine A.

J Am Med Inform Assoc. 2017 Jan;24(1):227-240. doi: 10.1093/jamia/ocw068. Epub 2016 Jun 14. Review.

PMID:
27301747
28.

Comprehensive cost analysis of sentinel node biopsy in solid head and neck tumors using a time-driven activity-based costing approach.

Crott R, Lawson G, Nollevaux MC, Castiaux A, Krug B.

Eur Arch Otorhinolaryngol. 2016 Sep;273(9):2621-8. doi: 10.1007/s00405-016-4089-z. Epub 2016 May 12.

PMID:
27170361
29.

Vacuum-assisted breast biopsies (VAB) carried out on an open 1.0T MR imager: Influence of patient and target characteristics on the procedural and clinical results.

Krug B, Hellmich M, Ulhaas A, Krämer S, Rhiem K, Zarghooni V, Püsken M, Schwabe H, Grinstein O, Markiefka B, Maintz D.

Eur J Radiol. 2016 Jun;85(6):1157-66. doi: 10.1016/j.ejrad.2016.02.030. Epub 2016 Mar 16.

PMID:
27161066
30.

Assessment of Primary Site Response in Children With High-Risk Neuroblastoma: An International Multicenter Study.

Bagatell R, McHugh K, Naranjo A, Van Ryn C, Kirby C, Brock P, Lyons KA, States LJ, Rojas Y, Miller A, Volchenboum SL, Simon T, Krug B, Sarnacki S, Valteau-Couanet D, von Schweinitz D, Kammer B, Granata C, Pio L, Park JR, Nuchtern J.

J Clin Oncol. 2016 Mar 1;34(7):740-6. doi: 10.1200/JCO.2015.63.2042. Epub 2016 Jan 11.

31.

Influence of hip replacement on sagittal alignment of the lumbar spine: An EOS study.

Bredow J, Katinakis F, Schlüter-Brust K, Krug B, Pfau D, Eysel P, Dargel J, Wegmann K.

Technol Health Care. 2015;23(6):847-54. doi: 10.3233/THC-151029.

PMID:
26409517
32.

Bacterial Contamination During Diagnostic and Interventional Neuroangiography is a Frequent Finding: But Does It Matter? An Observational Study.

Kabbasch C, Dorn F, Wenchel HM, Krug B, Mpotsaris A, Liebig T.

Clin Neuroradiol. 2017 Mar;27(1):39-42. doi: 10.1007/s00062-015-0431-x. Epub 2015 Aug 5.

PMID:
26242291
33.

Access to treatment for phenylketonuria by judicial means in Rio Grande do Sul, Brazil.

Trevisan LM, Nalin T, Tonon T, Veiga LM, Vargas P, Krug BC, Leivas PG, Schwartz IV.

Cien Saude Colet. 2015 May;20(5):1607-16. doi: 10.1590/1413-81232015205.08302014.

34.

Cost comparison of open approach, transoral laser microsurgery and transoral robotic surgery for partial and total laryngectomies.

Dombrée M, Crott R, Lawson G, Janne P, Castiaux A, Krug B.

Eur Arch Otorhinolaryngol. 2014 Oct;271(10):2825-34. doi: 10.1007/s00405-014-3056-9. Epub 2014 Jun 7.

PMID:
24906840
35.

A systematic review of the predictive value of (18)FDG-PET in esophageal and esophagogastric junction cancer after neoadjuvant chemoradiation on the survival outcome stratification.

Schollaert P, Crott R, Bertrand C, D'Hondt L, Borght TV, Krug B.

J Gastrointest Surg. 2014 May;18(5):894-905. doi: 10.1007/s11605-014-2488-2. Epub 2014 Mar 18. Review.

PMID:
24638928
36.

Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.

Carnevali L, Krug B, Amant F, Van Pee D, Gérard V, de Béthune X, Spinewine A.

Ann Pharmacother. 2013 Nov;47(11):1414-9. doi: 10.1177/1060028013500939.

PMID:
24285758
37.

A systematic review of the predictive value of 18F-fluoro-2-deoxyglucose positron emission tomography on survival in locally advanced rectal cancer after neoadjuvant chemoradiation.

Krug B, Crott R, de Cannière L, D'Hondt L, Vander Borght T.

Colorectal Dis. 2013 Nov;15(11):e627-33. doi: 10.1111/codi.12295. Review.

PMID:
24192263
38.

Polyurethane does not protect better than polyvinyl cuffed tracheal tubes from microaspirations.

Bulpa P, Evrard P, Bouhon S, Schryvers F, Jamart J, Michaux I, Dive A, Vander Borght T, Krug B.

Minerva Anestesiol. 2013 May;79(5):498-503. Epub 2013 Mar 19.

39.

Quality of life of brazilian patients with Gaucher disease and fabry disease.

Oliveira FL, Alegra T, Dornelles A, Krug BC, Netto CB, da Rocha NS, Picon PD, Schwartz IV.

JIMD Rep. 2013;7:31-7. doi: 10.1007/8904_2012_136. Epub 2012 Apr 18.

40.

Enzyme replacement therapy for Fabry disease: A systematic review and meta-analysis.

Alegra T, Vairo F, de Souza MV, Krug BC, Schwartz IV.

Genet Mol Biol. 2012 Dec;35(4 (suppl)):947-54. Epub 2012 Dec 18.

41.

CT coronary angiography: coronary CT-flow quantification supplements morphological stenosis analysis.

Bovenschulte H, Krug B, Schneider T, Schwabe H, Kabbasch C, Bangard C, Hellmich M, Michels G, Maintz D, Lackner K.

Eur J Radiol. 2013 Apr;82(4):608-16. doi: 10.1016/j.ejrad.2012.08.004. Epub 2012 Dec 21.

PMID:
23265182
42.

[Court-ordered access to treatment of rare genetic diseases: Fabry Disease in the state of Rio Grande do Sul, Brazil].

Sartori Junior D, Leivas PG, Souza MV, Krug BC, Balbinotto G, Schwartz IV.

Cien Saude Colet. 2012 Oct;17(10):2717-28. Portuguese.

43.

An atypical relapse of acute myeloid leukemia diagnosed by 18F-FDG PET/CT.

Schollaert P, Loosen C, André M, Chatelain B, Krug BM.

Clin Nucl Med. 2012 Oct;37(10):1018-21. doi: 10.1097/RLU.0b013e3182639712.

PMID:
22955081
44.

Morphometry of structural disconnectivity indicators in subjects at risk and in age-matched patients with schizophrenia.

Tepest R, Schwarzbach CJ, Krug B, Klosterkötter J, Ruhrmann S, Vogeley K.

Eur Arch Psychiatry Clin Neurosci. 2013 Feb;263(1):15-24. doi: 10.1007/s00406-012-0343-6. Epub 2012 Jul 21.

PMID:
22821623
45.

Imaging derived cortical thickness reduction in high-functioning autism: key regions and temporal slope.

Scheel C, Rotarska-Jagiela A, Schilbach L, Lehnhardt FG, Krug B, Vogeley K, Tepest R.

Neuroimage. 2011 Sep 15;58(2):391-400. doi: 10.1016/j.neuroimage.2011.06.040. Epub 2011 Jul 1.

PMID:
21749926
46.

Cortical representation sites of mimic movements after facial nerve reconstruction: a functional magnetic resonance imaging study.

Bitter T, Sorger B, Hesselmann V, Krug B, Lackner K, Guntinas-Lichius O.

Laryngoscope. 2011 Apr;121(4):699-706. doi: 10.1002/lary.21399. Epub 2011 Feb 1.

PMID:
21287559
47.

Ethical issues related to the access to orphan drugs in Brazil: the case of mucopolysaccharidosis type I.

Boy R, Schwartz IV, Krug BC, Santana-da-Silva LC, Steiner CE, Acosta AX, Ribeiro EM, Galera MF, Leivas PG, Braz M.

J Med Ethics. 2011 Apr;37(4):233-9. doi: 10.1136/jme.2010.037150. Epub 2011 Jan 25.

PMID:
21266385
48.

Transmurality of scar influences the effect of a hybrid-intervention with autologous bone marrow cell injection and aortocoronary bypass surgery (MNC/CABG) in patients after myocardial infarction.

Müller-Ehmsen J, Tossios P, Schmidt M, Scheid C, Unal N, Bovenschulte H, Hackenbroch M, Krug B, Goßmann A, Mehlhorn U, Schwinger RH, Erdmann E.

Int J Cardiol. 2012 May 3;156(3):303-8. doi: 10.1016/j.ijcard.2010.11.010. Epub 2010 Dec 24.

PMID:
21185612
49.

[High cost drugs for rare diseases in Brazil: the case of lysosomal storage disorders].

de Souza MV, Krug BC, Picon PD, Schwartz IV.

Cien Saude Colet. 2010 Nov;15 Suppl 3:3443-54. Review. Portuguese.

50.

In vitro measurements of flow using multislice computed tomography (MSCT).

Lackner K, Bovenschulte H, Stützer H, Just T, Al-Hassani H, Krug B.

Int J Cardiovasc Imaging. 2011 Jul;27(6):795-804. doi: 10.1007/s10554-010-9728-7. Epub 2010 Oct 24.

PMID:
20972834

Supplemental Content

Support Center